Mark De Rosch - Oct 28, 2021 Form 3 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Operating Officer
Signature
/s/ Julie Feder
Stock symbol
AURA
Transactions as of
Oct 28, 2021
Transactions value $
$0
Form type
3
Date filed
10/28/2021, 08:23 PM
Next filing
Nov 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AURA Stock Option (Right to Buy) Oct 28, 2021 Common Stock 56.6K $5.48 Direct F1
holding AURA Stock Option (Right to Buy) Oct 28, 2021 Common Stock 126K $5.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of Shares on the first anniversary of March 15, 2021 with the remainder vesting in 36 substantially equal monthly installments.
F2 The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following June 28, 2021.